Literature DB >> 728410

Acetylcholine receptor and ionic channel of Torpedo electroplax: binding of perhydrohistrionicotoxin to membrane and solubilized preparations.

M E Eldefrawi, A T Eldefrawi, N A Mansour, J W Daly, B Witkop, E X Albuquerque.   

Abstract

The electric organ of the ray, Torpedo ocellata, can serve as a source for both the acetylcholine (ACh) receptor and its ionic channel. The two entities were identified by their specific binding of [3H]ACh and [3H]perhydrohistrionicotoxin ([3H]H12-HTX), respectively. Binding of [3H]H12-HTX was inhibited by certain drugs and toxins, e.g., histrionicotoxin (HTX), amantadine, and tetraethylammonium (TEA) ions at concentrations that did not inhibit [3H]ACh binding. However, the specific carbamoylcholine-induced 22Na efflux from microsacs from the electric organ membranes was blocked by inhibitors of either the receptor or its ionic channel. The ionic channel had the properties of a protein as judged by heat sensitivity and the inhibition of [3H]H12-HTX binding, after incubation of the electric organ membranes with protein reagents such as p-chloromercuribenzenesulfonic acid (PCMBS) or N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). The "binding" of [3H]H12-HTX at 4 X 10(-8) M to lipids in the microsacs was 12% of the total binding to intact microsacs and was nonsaturable and insensitive to heat or specific drugs. After solubilization with cholate, the [3H]H12-HTX binding subunits retained the same affinities for toxins and drugs. The Kd for [3H]H12-HTX was 3 X 10(-7) M. The majority of the ionic channel could be separated from the ACh receptors in the cholate extract by incubation with ACh-receptor affinity gel and ACh-receptor antibodies. The ACh receptor purified by this affinity gel contained only a few active ionic channel units as judged by low levels of high affinity binding of [3H]H12-HTX. On the other hand, after solubilization with Triton X-100, all the ionic channel molecules were either separated or denatured so that the purified ACh receptor did not exhibit high affinity binding for [3H]H12-HTX.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728410     DOI: 10.1021/bi00618a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

Review 2.  Acetylcholine receptor kinetics.

Authors:  P R Adams
Journal:  J Membr Biol       Date:  1981-02-28       Impact factor: 1.843

3.  Inactivation (desensitization) of the acetylcholine receptor in Electrophorus electricus membrane vesicles by carbamylcholine: comparison between ion flux and alpha-bungarotoxin binding.

Authors:  N Epstein; G P Hess; P S Kim; R L Noble
Journal:  J Membr Biol       Date:  1980-09-30       Impact factor: 1.843

4.  Triphenylmethylphosphonium is an ion channel ligand of the nicotinic acetylcholine receptor.

Authors:  L Lauffer; F Hucho
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane.

Authors:  E X Albuquerque; M C Tsai; R S Aronstam; B Witkop; A T Eldefrawi; M E Eldefrawi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

6.  Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin.

Authors:  M E Eldefrawi; R S Aronstam; N M Bakry; A T Eldefrawi; E X Albuquerque
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

7.  [3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor.

Authors:  M E Eldefrawi; A T Eldefrawi; R S Aronstam; M A Maleque; J E Warnick; E X Albuquerque
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.